Literature DB >> 19470834

Relative effects of estrogen, age, and visceral fat on pulsatile growth hormone secretion in healthy women.

Johannes D Veldhuis1, Susan B Hudson, Dana Erickson, Joy N Bailey, George Ann Reynolds, Cyril Y Bowers.   

Abstract

Growth hormone (GH) secretion is subject to complex regulation. How pre- and postmenopausal age (PRE, POST), estradiol (E(2)) availability, and abdominal visceral fat (AVF) jointly affect peptidyl-secretagogue drive of GH secretion is not known. To this end, healthy PRE (n = 20) and POST (n = 22) women underwent a low- vs. high-E(2) clamp before receiving a continuous intravenous infusion of GH-releasing hormone (GHRH) or GH-releasing peptide (GHRP-2). According to analysis of covariance, PRE and POST women achieved age-independent hypo- and euestrogenemia under respective low- and high-E(2) clamps. All four of age (P < 0.001), E(2) status (P = 0.006), secretagogue type (P < 0.001), and an age x peptide interaction (P = 0.014) controlled pulsatile GH secretion. Independently of E(2) status, POST women had lower GH responses to both GHRH (P = 0.028) and GHRP-2 (P < 0.001) than PRE women. Independently of age, GHRP-2 was more stimulatory than GHRH during low E(2) (P = 0.011) and high E(2) (P < 0.001). Stepwise forward-selection multivariate analysis revealed that computerized tomographic estimates of AVF explained 22% of the variability in GHRH action (P = 0.002), whereas age and E(2) together explained 60% of the variability in GHRP-2 drive (P < 0.001). These data establish that age, estrogen status, and AVF are triple covariates of continuous peptide-secretagogue drive of pulsatile GH secretion in women. Each factor must be controlled for to allow valid comparisons of GH-axis activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19470834      PMCID: PMC2724113          DOI: 10.1152/ajpendo.00230.2009

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  47 in total

1.  Physiological control of pituitary hormone secretory-burst mass, frequency, and waveform: a statistical formulation and analysis.

Authors:  Daniel M Keenan; Ferdinand Roelfsema; Nienke Biermasz; Johannes D Veldhuis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-05-08       Impact factor: 3.619

2.  Lowering total plasma insulin-like growth factor I concentrations by way of a novel, potent, and selective growth hormone (GH) receptor antagonist, pegvisomant (B2036-peg), augments the amplitude of GH secretory bursts and elevates basal/nonpulsatile GH release in healthy women and men.

Authors:  J D Veldhuis; M Bidlingmaier; S M Anderson; Z Wu; C J Strasburger
Journal:  J Clin Endocrinol Metab       Date:  2001-07       Impact factor: 5.958

3.  Somatostatin is required for masculinization of growth hormone-regulated hepatic gene expression but not of somatic growth.

Authors:  M J Low; V Otero-Corchon; A F Parlow; J L Ramirez; U Kumar; Y C Patel; M Rubinstein
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

4.  Effects of estrogen and sex difference on secretion of human growth hormone.

Authors:  A G Frantz; M T Rabkin
Journal:  J Clin Endocrinol Metab       Date:  1965-11       Impact factor: 5.958

5.  Half-time of endogenous growth hormone (GH) disappearance in normal man after stimulation of GH secretion by GH-releasing hormone and suppression with somatostatin.

Authors:  A C Faria; J D Veldhuis; M O Thorner; M L Vance
Journal:  J Clin Endocrinol Metab       Date:  1989-03       Impact factor: 5.958

6.  Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release.

Authors:  M L Hartman; S M Pincus; M L Johnson; D H Matthews; L M Faunt; M L Vance; M O Thorner; J D Veldhuis
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

7.  Aromatase and 5alpha-reductase inhibition during an exogenous testosterone clamp unveils selective sex steroid modulation of somatostatin and growth hormone secretagogue actions in healthy older men.

Authors:  Johannes D Veldhuis; Kristi L Mielke; Mihaela Cosma; Cacia Soares-Welch; Remberto Paulo; John M Miles; Cyril Y Bowers
Journal:  J Clin Endocrinol Metab       Date:  2008-12-16       Impact factor: 5.958

8.  Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland.

Authors:  G Muccioli; C Ghè; M C Ghigo; M Papotti; E Arvat; M F Boghen; M H Nilsson; R Deghenghi; H Ong; E Ghigo
Journal:  J Endocrinol       Date:  1998-04       Impact factor: 4.286

9.  Evidence for direct action of estradiol on growth hormone-releasing factor (GRF) in rat hypothalamus: localization of [3H]estradiol in GRF neurons.

Authors:  K Shirasu; W E Stumpf; M Sar
Journal:  Endocrinology       Date:  1990-07       Impact factor: 4.736

Review 10.  Three-peptide control of pulsatile and entropic feedback-sensitive modes of growth hormone secretion: modulation by estrogen and aromatizable androgen.

Authors:  Johannes D Veldhuis; Cyril Y Bowers
Journal:  J Pediatr Endocrinol Metab       Date:  2003-05       Impact factor: 1.634

View more
  9 in total

1.  Multipathway modulation of exercise and glucose stress effects upon GH secretion in healthy men.

Authors:  Johannes D Veldhuis; Thomas P Olson; Paul Y Takahashi; John M Miles; Michael J Joyner; Rebecca J Yang; Jean Wigham
Journal:  Metabolism       Date:  2015-05-15       Impact factor: 8.694

Review 2.  Insulin-resistance in paediatric age: Its magnitude and implications.

Authors:  Mohammed Al-Beltagi; Adel Salah Bediwy; Nermin Kamal Saeed
Journal:  World J Diabetes       Date:  2022-04-15

3.  Endogenous Estrogen Regulates Somatostatin-Induced Rebound GH Secretion in Postmenopausal Women.

Authors:  Johannes D Veldhuis; Dana Erickson; Rebecca Yang; Paul Takahashi; Cyril Bowers
Journal:  J Clin Endocrinol Metab       Date:  2016-07-26       Impact factor: 5.958

4.  Growth Hormone Dynamics in Healthy Adults Are Related to Age and Sex and Strongly Dependent on Body Mass Index.

Authors:  Ferdinand Roelfsema; Johannes D Veldhuis
Journal:  Neuroendocrinology       Date:  2015-07-28       Impact factor: 4.914

5.  Decreased IGF-1 concentration during the first trimester of pregnancy in women with normal somatotroph function.

Authors:  Marie-Laure Persechini; Isabelle Gennero; Solange Grunenwald; Delphine Vezzosi; Antoine Bennet; Philippe Caron
Journal:  Pituitary       Date:  2015-08       Impact factor: 4.107

6.  Pre- versus postmenopausal age, estradiol, and peptide-secretagogue type determine pulsatile growth hormone secretion in healthy women: studies using submaximal agonist drive and an estrogen clamp.

Authors:  Susan B Hudson; Darrell R Schroeder; Joy N Bailey; Kristi L Mielke; Dana Erickson; John M Miles; Cyril Y Bowers; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2009-10-26       Impact factor: 5.958

Review 7.  Biological effects of growth hormone on carbohydrate and lipid metabolism.

Authors:  Archana Vijayakumar; Ruslan Novosyadlyy; Yingjie Wu; Shoshana Yakar; Derek LeRoith
Journal:  Growth Horm IGF Res       Date:  2009-10-01       Impact factor: 2.372

8.  Ovariectomy and overeating palatable, energy-dense food increase subcutaneous adipose tissue more than intra-abdominal adipose tissue in rats.

Authors:  Viktoria Gloy; Wolfgang Langhans; Jacquelien Jg Hillebrand; Nori Geary; Lori Asarian
Journal:  Biol Sex Differ       Date:  2011-05-11       Impact factor: 5.027

Review 9.  The Role of the Growth Hormone/Insulin-Like Growth Factor System in Visceral Adiposity.

Authors:  Moira S Lewitt
Journal:  Biochem Insights       Date:  2017-04-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.